Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Fish and Richardson
Johnson and Johnson
Accenture
Harvard Business School
AstraZeneca

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 6,635,458

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,635,458
Title: Enzymatic process for the preparation of cephalosporanic 7$B(G)-(4-Carboxybutanamide) acid by means of the modified enzyme D-aminoacid oxidase of trigonopsis variabilis produced in escherichia coli
Abstract:Enzymatic process for the preparation of cephalosporanic 7.beta.-(4-carboxybutanamide) acid by using the modified enzyme D-aminoacid oxidase of Trigonopsis variabilis produced in Escherichia coli. The process for the expression of the enzyme comprises: (I) isolating the DNA corresponding to gene which codes for the enzyme D-aminoacid oxidase; (II) removing the intron which is contained in said gene; (III) inserting the DNA fragment obtained into the plasmide which is capable of replication in Escherichia coli; (IV) fusing at the extremity 5\' of the structural region of the gene a synthetic assembler which contains a nucleotide sequence which codes for six histidines; (V) transforming a strain of Escherichia coli with the resulting recombinant plasmide; (VI) cultivating the transformed cells of Escherichia coli; and (VII) recovering the enzyme D-aminoacid oxidase of the former cultivation operation through affinity chromatography.
Inventor(s): Garcia Lopez; Jose Luis (Madrid, ES), Cortes Rubio; Estrella (Madrid, ES), Alonso Palacios; Jorge (Madrid, ES), Mellado Duran; Encarnacion (Leon, ES), Diez Garcia; Bruno (Leon, ES), Guisan Seijas; Jose Manuel (Madrid, ES), Salto Maldonado; Franciso (Madrid, ES), Fuente; Barredo (Leon, ES)
Assignee: Antibioticos, S.A.U. (Leon, ES)
Application Number:09/308,683
Patent Claims:see list of patent claims

Details for Patent 6,635,458

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up Antibioticos, S.A.U. (Leon, ES) 2017-09-25 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up Antibioticos, S.A.U. (Leon, ES) 2017-09-25 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up Antibioticos, S.A.U. (Leon, ES) 2017-09-25 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
UBS
Fish and Richardson
AstraZeneca
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.